Giorgio Minotti Selected Research

Phthalic Acids

2/2004

Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Minotti Research Topics

Disease

43	Cardiotoxicity 01/2022 - 09/2002
29	Neoplasms (Cancer) 01/2022 - 09/2003
14	Heart Failure 01/2022 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2003
6	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 07/2010
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 02/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2022 - 04/2017
2	Myocardial Infarction 12/2021 - 09/2013
2	Philadelphia Chromosome 01/2020 - 04/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
2	Tachycardia (Tachyarrhythmias) 01/2019 - 12/2018
2	Infections 01/2018 - 08/2011
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Systolic Heart Failure 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Pulmonary Embolism 10/2020
1	Venous Thromboembolism 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2019
1	Left Ventricular Dysfunction 12/2019
1	Multiple Myeloma 12/2019
1	Anemia 01/2019
1	Necrosis 12/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2018
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2018
1	Atrial Fibrillation 10/2018
1	Hemorrhage 10/2018

Drug/Important Bio-Agent (IBA)

42	AnthracyclinesIBA 01/2022 - 09/2002
27	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2002
10	Pharmaceutical PreparationsIBA 01/2021 - 05/2008
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2012 - 04/2004
6	IronIBA 01/2008 - 06/2002
5	Antineoplastic Agents (Antineoplastics)IBA 09/2013 - 06/2004
5	Epirubicin (Ellence)FDA LinkGeneric 05/2012 - 06/2004
5	quinone (benzoquinone)IBA 01/2010 - 01/2004
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2017
4	Trastuzumab (Herceptin)FDA Link 04/2019 - 01/2007
4	pixantrone (BBR 2778)IBA 01/2018 - 02/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 01/2003
3	Ranolazine FDA Link 01/2022 - 09/2013
3	SodiumIBA 01/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
3	ponatinibIBA 01/2020 - 04/2017
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 11/2017
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 02/2013
3	AnthraquinonesIBA 01/2018 - 02/2013
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013 - 06/2009
3	adriamycinolIBA 02/2013 - 07/2006
3	hydroquinone (Esoterica)FDA Link 01/2010 - 01/2008
3	taxaneIBA 02/2007 - 07/2006
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 11/2020
2	AnticoagulantsIBA 10/2020 - 10/2018
2	TroponinIBA 12/2018 - 11/2017
2	Superoxides (Superoxide)IBA 02/2013 - 05/2012
2	liposomal doxorubicin (Doxil)FDA Link 12/2012 - 11/2011
2	AntioxidantsIBA 01/2010 - 09/2002
2	Free RadicalsIBA 01/2008 - 06/2004
2	Docetaxel (Taxotere)FDA Link 02/2007 - 07/2006
2	Taxoids (Taxanes)IBA 02/2007 - 01/2007
2	ferrylmyoglobinIBA 02/2004 - 09/2002
2	Aconitate Hydratase (Aconitase)IBA 06/2003 - 06/2002
1	Phosphodiesterase InhibitorsIBA 01/2022
1	tafasitamabIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	loncastuximab tesirineIBA 01/2022
1	blinatumomabIBA 01/2022
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Sodium-Glucose Transport ProteinsIBA 11/2021
1	midostaurinIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020
1	AndrogensIBA 12/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019
1	Cardiovascular AgentsIBA 01/2019
1	Troponin IIBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2018
1	ibrutinibIBA 10/2018

Therapy/Procedure

21	Therapeutics 01/2022 - 04/2006
11	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
1	Precision Medicine 01/2021
1	Long-Term Care 12/2020
1	Aftercare (After-Treatment) 06/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2019